Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

1.0K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.0K
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

569
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
569
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

957
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
957
Drug Therapy01:28

Drug Therapy

153
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
153
Depression: Overview01:18

Depression: Overview

549
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
549
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

387
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
387

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lithium: challenges of being king.

The British journal of psychiatry : the journal of mental science·2026
Same author

Antidepressant Prescribing in Australian Primary Care: Time to Reevaluate.

The Medical journal of Australia·2026
Same author

Screening for perinatal depression in Australia: Validation of the Edinburgh Postnatal Depression Scale in pregnancy and the postpartum.

The Australian and New Zealand journal of psychiatry·2025
Same author

Commentary on the Canadian Network for Mood and Anxiety Treatments 2024 Clinical Practice Guideline for the Management of Perinatal Mood, Anxiety and Related Disorders: Evidence-Based Treatments Require Appropriate Systems of Care to Be Implemented.

Canadian journal of psychiatry. Revue canadienne de psychiatrie·2025
Same author

Treatment resistant but not irremediable.

Bipolar disorders·2024
Same author

Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial.

The British journal of psychiatry : the journal of mental science·2023
Same journal

Dual antihypertensive fixed-dose combinations approved for first-line use on the Pharmaceutical Benefits Scheme.

Australian prescriber·2026
Same journal

Capivasertib for locally advanced or metastatic breast cancer.

Australian prescriber·2026
Same journal

Diagnosis and management of irritable bowel syndrome.

Australian prescriber·2026
Same journal

Stopping antidepressants: when and how.

Australian prescriber·2026
Same journal

Emergency contraception: an overview.

Australian prescriber·2026
Same journal

Sodium valproate: balancing benefits and risks especially in people of childbearing potential.

Australian prescriber·2026
See all related articles

Related Experiment Video

Updated: Nov 15, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

345

Choosing an antidepressant.

Philip Boyce1, Cassandra Ma1

  • 1Specialty of Psychiatry, Westmead Clinical School, Sydney Medical School, Faculty of Medicine and Health, University of Sydney.

Australian Prescriber
|March 5, 2021
PubMed
Summary
This summary is machine-generated.

Effective depression management integrates biopsychosocial and lifestyle factors. While psychological therapies and antidepressants are proven, not all primary care patients need medication, emphasizing shared decision-making.

Keywords:
depressionselective serotonin reuptake inhibitorstricyclic antidepressants

More Related Videos

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

29.1K
The Mouse Forced Swim Test
06:19

The Mouse Forced Swim Test

Published on: January 29, 2012

106.7K

Related Experiment Videos

Last Updated: Nov 15, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

345
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

29.1K
The Mouse Forced Swim Test
06:19

The Mouse Forced Swim Test

Published on: January 29, 2012

106.7K

Area of Science:

  • Clinical Psychology
  • Psychiatry
  • Primary Care Medicine

Background:

  • Depression is a complex condition requiring a comprehensive management approach.
  • Primary care settings frequently encounter patients with depression.
  • Current guidelines advocate for evidence-based treatments for depression.

Purpose of the Study:

  • To outline a biopsychosocial and lifestyle approach for managing depression.
  • To emphasize the role of patient education and shared decision-making in depression care.
  • To guide the selection of antidepressant pharmacotherapy when indicated.

Main Methods:

  • Review of evidence-based treatments for depression.
  • Integration of psychological therapies and pharmacotherapy considerations.
  • Focus on patient-centered care principles.

Main Results:

  • A biopsychosocial and lifestyle approach is recommended for depression management.
  • Psychological therapies and antidepressant drugs are effective treatments.
  • Not all primary care patients with depression necessitate drug therapy.

Conclusions:

  • Holistic management of depression is crucial.
  • Shared decision-making is vital when prescribing antidepressants.
  • Antidepressant selection should consider efficacy, tolerability, presentation, patient preference, and drug interactions.